LGR5 and neoplasm: These results support a model in which tumor cells undergo dynamic cell-state transitions between LGR5+ and LGR5−, contributing to tumor heterogeneity, progression, and metastatic potential, emphasizing the importance of targeting dynamic CSC states for effective therapeutic strategies.